$goog making 52 week lows while gemini renters the frontier race and nvidia falters ~ TPU’s positioning improves….
Interesting set-up. Thoughts here?
@WaterworldCapi1 @akramsrazor
1
2
218
Anthropic next gen cyber product release in 3,2,1….. $ANT
5 MAJOR DISRUPTIONS IN JUST 6 DAYS
🇺🇸 Nov 17: NSA classified network DOWN
🏦 Nov 16: JPMorgan banking failure
✈️ Nov 16: United Airlines outage
🛑 Nov 13: FAA nationwide ground stop
🌐 Nov 12–13: Microsoft 365 outage
No coordinated cyberattack confirmed.
2
182
Anyone have an opinion on $shaz here?
Perhaps not as shitty as it used to be and at $20 underwriting very little execution
@ACapitalLP @YellowCatCap @kevin__mak
2
1
2,329
FYI this was inevitable once the labs began going public…multi trillion dollar valuations needs more markets = they’re coming after SaaS.
(The biotech stuff is mostly pipe dreams for now).
$Ant $igv
Starting to roll out today: Claude Whiteboards, Claude Sheets and Claude Data.
Think a plan through on a board, build a tracker in a sheet, and tell a story with your data.
2
2
1,004
bear celebrating too fast IMO. This will be a different kind of decel…
Also solar interesting here as pretty cheap and your probably looking at 6 years of incredible runway from a regulatory perspective…
1
1
298
Bought $mgm today.
Probably should have bought more but also don’t really like the buisness.
And…we have arrived..
This will probably be my last time commenting on this for a while.
Market has provided an opportunity for people with 12-18 month horizon imo. I’ve taken it and am now sized the way i’d like.
On to the next one..;) @Biohazard3737
Replying to @Michaelrose102
2
7
587
And now kind of asking the same question about $zura…
Not crazy about it and specialists + the market are staying away but the r/r has certainly changed (gotten better) …@Biohazard3737
Not necessarily a big fan of $iva but price action of late has certainly changed the
r/r….
Anybody negative here with conviction?
1
1,018
Went to $14-15 premarket - now back to $10.
Back in the good days they would’ve squeezed this to $40…watching this one in case we get some inter day action
@SPACLiquidity
$ATII
There were 23,000,000 shares subject to possible redemption.
Shareholders elected to redeem 22,219,068 shares of Class A common stock in connection with the meeting.
780,982 shares remain in the public float
1
264
I have resigned myself to waiting to double my position when it gets into the 7’s….probably means it never gets there…
@EricTheUmpire
226
$AVR. I’ve been adding.
•Enrollment has been going well (should finish on time Q1 ‘27).
•Ex-pivotal data 1 year 130 patients in November will help de-risk PARADIGM (CEO has seen data - said “consistent with public data”)
•Recent deals show how cheap it’s here
@Biohazard3737
$AVR Not the kind of name you traditionally look to buy in current market dynamic…
But time arbitrage if I’ve ever seen one - and it’s not a bad thing to buy things when no one else wants to because “it’s not the time”
@Biohazard3737 @avidresearch @Sanctuary_Bio
R/R here is egregious IMO.
From this levels
Pre pivotal data prob downside of $1.25 - upside of $7-8 (IMO fair range pre readout is $12-16)
Post data - downside 50% - upside 4x. And that’s for something with consensus high POS
1
1
397
Just saying an AI slowdown and restrictive posture / rate hikes would be a disaster - and are also probably mutually exclusive…
1
332
Not necessarily a big fan of $iva but price action of late has certainly changed the
r/r….
Anybody negative here with conviction?
$ccxi I’m not a LT bull. But the r/r here is wild.
Only U.SA. humanoid pure play - every private name is ridiculously valued - $amzn owns 7% - $nvda keeps talking them up - and you have NAV protection.
Risk a dollar to make $6-7 on a run up into a vote?
The one consolation if you missed $CCXI is:
There will most likely be a short report at some point pointing at the lack of revenue + how the pilots are meh because customers just taking multiple pilots at a time and then drop.
And the Market will care for 1-2 hours. You BTD 🚀
And there you go…
$pcvx
“$500 million of its common stock and pre-funded warrants and $500 million aggregate principal amount of convertible senior notes due 2032..”
teapawt.net/monaco_biotech/status/…
1
2
535
$pcvx
Wow. Anyone hear pricing here? Surprised to see this back in low 60’s so quickly… @tradingbios @plainyogurt21 @BlaseBio @Sanctuary_Bio
76







